The complexities of the cardiovascular actions of cannabinoids

British Journal of Pharmacology

Volumn 142, Issue 1, 2004, Pages 20-26

  Randall, Michael D ^a   Kendall, David A ^a   O'Sullivan, Saoirse ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Anandamide; Cannabinoids; EDHF; Endothelium; Sensory nerves; Vanilloid receptors

Indexed keywords

CANNABINOID;

ADRENERGIC SYSTEM; BLOOD VESSEL REACTIVITY; BRADYCARDIA; CARDIOVASCULAR EFFECT; DRUG MECHANISM; DRUG METABOLISM; HYPOTENSION; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; SHORT SURVEY; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALS; ARACHIDONIC ACIDS; CANNABINOIDS; CARDIOVASCULAR SYSTEM; HUMANS; POLYUNSATURATED ALKAMIDES; VASODILATION;

EID: 2542555018     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705725     Document Type: Short Survey

References (65)

1. ANDERSSON, D.A., ADNER, M., HÖGESTATT, E.D. & ZYGMUNT, P.M. (2002). Mechanisms underlying tissue selectivity of anandamide and other vanilloid receptor agonists. Mol. Pharmacol., 62, 705-713.
2. CHAYTOR, A.T., MARTIN, P.E., EVANS, W.H., RANDALL, M.D. & GRIFFITH, T.M. (1999). The endothelial component of cannabinoid-induced relaxation in rabbit mesenteric artery depends on gap junctional communication. J. Physiol., 520, 539-550.
3. 1) receptor expression is associated with mesenteric resistance vessels but not thoracic aorta in the rat. Br. J. Pharmacol., 125, 95P.
4. DEUTSCH, D.G., GOLIGORSKY, M.S., SCHMID, P.C., KREBSBACH, R.J., SCHMID, H.H., DAS, S.K., DEY, S.K., ARREAZA, G., THORUP, C., STEFANO, G. & MOORE, L.C. (1997). Production and physiological actions of anandamide in the vasculature of the rat kidney. J. Clin. Invest., 100, 1538-1546.
5. DEWEY, W.L. (1986). Cannabinoid pharmacology. Pharmacol. Rev., 38, 151-178.
6. ELLIS, E.F., MOORE, S.F. & WILLOUGHBY, K.A. (1995). Anandamide and delta 9-THC dilation of cerebral arterioles is blocked by indomethacin. Am. J. Physiol., 269, H1859-H1864.
7. FLEMING, I., SCHERMER, B., POPP, R. & BUSSE, R. (1999). Inhibition of the production of endothelium-derived hyperpolarizing factor by cannabinoid receptor agonists. Br. J. Pharmacol., 126, 949-960.
8. FORD, W.R., HONAN, S.A., WHITE, R. & HILEY, C.R. (2002). Evidence of a novel site mediating anandamide-induced negative inotropic and coronary vasodilator responses in rat isolated hearts. Br. J. Pharmacol., 135, 1191-1198.
9. GARCIA, N., JARAI, Z., MIRSHAHI, F., KUNOS, G. & SANYAL, A.J. (2001). Systemic and portal hemodynamic effects of anandamide. Am. J. Physiol., 280, G14-G20.
10. GARDINER, S.M., MARCH, J.E., KEMP, P.A. & BENNETT, T. (2001). Regional haemodynamic responses to the cannabinoid agonist, WIN 55212-2, in conscious, normotensive, and in hypertensive, transgenic rats. Br. J. Pharmacol., 133, 445-453.
11. GARDINER, S.M., MARCH, J.E., KEMP, P.A. & BENNETT, T. (2002a). Complex regional haemodynamic effects of anandamide in conscious rats. Br. J. Pharmacol., 135, 1889-1896.
12. 1 receptor antagonist, AM 251, on the regional haemodynamic effects of WIN 55212-2 or HU 210 in conscious rats. Br. J. Pharmacol., 136, 581-587.
13. 2+ channel current. Am. J. Physiol., 276, H2085-93.
14. GRAINGER, J. & BOACHIE-ANSAH, G. (2001). Anandamide-induced relaxation of sheep coronary arteries: the role of the vascular endothelium, arachidonic acid metabolites and potassium channels. Br. J. Pharmacol., 134, 1003-1012.
15. HARRIS, D., MCCULLOCH, A.I., KENDALL, D.A. & RANDALL, M.D. (2002). Characterisation of vasorelaxant responses to anandamide in the rat mesenteric arterial bed. J. Physiol., 539, 893-902.
16. HILLARD, C.J. (2000). Endocannabinoids and vascular function. J. Pharmacol Exp. Ther., 294, 27-32.
17. 2+ influx. Br. J. Pharmacol., 139, 585-597.
18. HÖGESTATT, E.D. & ZYGMUNT, P.M. (2002). Cardiovascular pharmacology of anandamide. Prostag Leukotr. Essent. Fatty Acids, 66, 343-351.
19. 1 receptors fail to cause relaxation, but couple via Gi/Go to inhibition of adenyl cyclase in carotid artery smooth muscle. Br. J. Pharmacol., 128, 597-604.
20. HUESTIS, M.A., GORELICK HEISHMAN, S.J., PRESTON, K.L., NELSON, R.A., MOOLCHAN, E.T. & FRANK, R.A. (2001). Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist. Arch. Gen. Psychiatry, 58, 322-328.
21. JÁRAI, Z., WAGNER, J.A., GOPARAJU, S.K., WANG, L., RAZADAN, R.K., SUGIURA, T., ZIMMER, A.M., BONNER, T.I., ZIMMER, A. & KUNOS, G. (2000). Cardiovascular effects of 2-arachidonoyl glycerol in anaesthetized mice. Hypertension, 35, 679-684.
22. JÁRAI, Z., WAGNER, J.A., VARGA, K., LAKE, K.D., COMPTON, D.R., MARTIN, B.R., ZIMMER, A.M., BONNER, T.I., BUCKLEY, N.B., MEZEY, E., RAZDAN, R.K., ZIMMER, A. & KUNOS, G. (1999). Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc. Natl. Acad. Sci. USA, 96, 14136-14141.
23. JONES, R.T. (2002). Cardiovascular system effects of marijuana. J. Clin. Pharmacol., 42, 58S-63S (Suppl.).
24. KAGOTA, S., YAMAGUCHI, Y., NAKAMURA, K., SUGIURA, T., WAKU, K. & KUNITOMO, M. (2001). 2-Arachidonoylglycerol, a candidate of endothelium-derived hyperpolarizing factor. Eur J Pharmacol., 415, 233-238.
25. KENNY, L.C., BAKER, P.N., KENDALL, D.A., RANDALL, M.D. & DUNN, W.R. (2002). The role of gap junctions in mediating endothelium-dependent responses to bradykinin in myometrial small arteries isolated from pregnant women. Br. J. Pharmacol., 136, 1085-1088.
26. KUNOS, G., JÁRAI, Z., BATKAI, S., GOPARAJU, S.K., ISHAC, E.J.N., LIU, J., WANG, L. & WAGNER, J.A. (2000). Endocannabinoids as cardiovascular modulators. Chem. Phys. Lipids, 108, 159-168.
27. LAGNEUX, C. & LAMONTAGNE, D. (2001). Involvement of cannabinoids in the cardioprotection induced by lipopolysaccharide. Br. J. Pharmacol., 132, 793-796.
28. LAKE, K.D., MARTIN, B.R., KUNOS, G. & VARGA, K. (1997). Cardiovascular effects of anandamide in anaesthetized and conscious normotensive rats. Hypertension, 29, 1204-1210.
29. 1 receptor knockout mice. Science, 283, 401-404.
30. LEPICIER, P., BOUCHARD, J-F., LAGNEUX, C. & LAMONTAGNE, D. (2003). Endocannabinoids protect the rat isolated heart against ischaemia. Br. J. Pharmacol., 139, 805-815.
31. + channel TASK-1. EMBO J., 20, 47-54.
32. MALINOWSKA, B., KWOLEK, G. & GOTHERT, M. (2001). Anandamide and methanandamide induce both vanilloid VR1- and cannabinoid CB1 receptor-mediated changes in heart rate and blood pressure in anaesthetized rats. Nauyn-Schmiedeberg's Arch. Pharmacol., 364, 562-569.
33. MECHOULAM, R., FRIDE, E., BEN-SHABAT, S., MEIRI, U. & HOROWITZ, M. (1998). Carbachol, an acetylcholine receptor agonist, enhances production in the rat aorta of 2-arachidonoyl glycerol, a hypotensive endocannabinoid. Eur. J. Pharmacol., 362, R1-R3.
34. MUKHOPADHYAY, S., CHAPNICK, B.M. & HOWLETT, A.C. (2002). Anandamide-induced vasorelaxation in rabbit aortic rings has two components: G protein dependent and independent. Am. J. Physiol., 282, H2046-H2054.
35. NIEDERHOFFER, N., SCHMID, K. & SZABO, B. (2003). The peripheral sympathetic nervous system is the major target of cannabinoids in eliciting cardiovascular depression. Nauyn-Schmiedeberg's Arch. Pharmacol., 367, 434-443.
36. NIEDERHOFFER, N. & SZABO, B. (1999). Effect of the cannabinoid receptor agonist WIN55212-2 on sympathetic cardiovascular regulation. Br. J. Pharmacol., 126, 457-466.
37. NIEDERHOFFER, N. & SZABO, B. (2000). Cannabinoids cause central sympathoexcitation and bradycardia in rabbits. J. Pharmacol. Exp. Ther., 294, 707-713.
38. OFFERTÁLER, L., MO, F.M., BATKAI, S., LIU, J., BEGG, M., RAZDAN, R.K., MARTIN, B.R., BUKOSKI, R.D. & KUNOS, G. (2003). Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor. Mol. Pharmacol., 63, 699-705.
39. O'SULLIVAN, S.E., KENDALL, D.A. & RANDALL, M.D. (2004a). Chronic administration of the cannabinoid CP55,940 inhibits the vasorelaxant effects of cannabinoids in the isolated rat aorta. Br. J. Pharmacol., (abstract, Manchester meeting, in press).
40. O'SULLIVAN, S.E., KENDALL, D.A. & RANDALL, M.D. (2004b). Characterisation of the vasorelaxant properties of the novel endocannabinoid N-arachidonoyl-dopamine (NADA). Br. J. Pharmacol., (in press).
41. PADLEY, J.R., LI, Q., PILOWSKY, P.M. & GOODCHILD, A.K. (2003). Cannabinoid receptor activation in the rostral ventrolateral medulla oblongata evokes cardiorespiratory effects in anaesthetised rats. Br. J. Pharmacol., 140, 384-394.
42. 1 cannabinoid receptor. Am. J. Physiol., 274, H375-H381.
43. RADEMACHER, D.J., PATEL, S., HOPP, F.A., DEAN, C., HILLARD, C.J. & SEAGARD, J.L. (2003). Microinjection of a cannabinoid receptor antagonist into the NTS increases baroreflex duration in dogs. Am. J. Physiol., 284, H1570-H1576.
44. RALEVIC, V. (2003). Cannabinoid modulation of peripheral autonomic and sensory neurotransmission. Eur. J. Pharmacol., 471, 1-21.
45. RALEVIC, V., KENDALL, D.A., RANDALL, M.D. & SMART, D. (2002). Cannabinoid modulation of sensory neurotransmission via cannabinoid and vanilloid receptors: roles in regulation of cardiovascular function. Life Sci., 71, 2577-2594.
46. RALEVIC, V., KENDALL, D.A., RANDALL, M.D., ZYGMUNT, P.M., MOVAHED, P. & HÖGESTATT, E.D. (2000). Vanilloid receptors on capsaicin-sensitive nerves mediate relaxation to methanandamide in the rat isolated mesenteric bed. Br. J. Pharmacol., 130, 1483-1488.
47. RANDALL, M.D. & KENDALL, D.A. (1997). Involvement of a cannabinoid in endothelium-derived hyperpolarizing factor-mediated coronary vasorelaxation. Eur. J. Pharmacol., 335, 205-209.
48. RANDALL, M.D., HARRIS, D., KENDALL, D.A. & RALEVIC, V. (2002). Cardiovascular effects of cannabinoids. Pharmacol. Ther., 95, 191-202.
49. RANDALL, M.D. & KENDALL, D.A. (1998). Anandamide and endothelium-derived hyperpolarizing factor act via a common vasorelaxant mechanism in rat mesentery. Eur. J. Pharmacol., 346, 51-53.
50. SEACARD, J.L., DEAN, C., PATEL, S., RADEMACHER, D.J., HOPP, F.A., SCHMELING, W.T. & HILLARD, C.J. (2004). Anandamide content and interaction of endocannabinoid/GABA modulatory effects in the NTS on baroreflex-evoked sympathoinhibition. Am. J. Physiol., 286, H992-H1000.
51. SMITH, P.J.W. & MCQUEEN, D.S. (2001). Anandamide induces cardiovascular and respiratory reflexes via vasosensory nerves in that anaesthetized rat. Br. J. Pharmacol., 134, 655-663.
52. STARK, P. & DEWS, P.B. (1980). Cannabinoids. II. Cardiovascular effects. J. Pharmacol. Exp. Ther., 214, 131-138.
53. STEIN, E.A., FULLER, S.A., EDGEMOND, W.S. & CAMPBELL, W.B. (1996). Physiological and behavioural effects of the endogenous cannabinoid, arachidonylethanolamine (anandamide), in the rat. Br. J. Pharmacol., 119, 107-114.
54. VANHEEL, B. & VAN DE VOORDE, J. (2001). Regional differences in anandamide- and methanandamide-induced membrane potential changes in rat mesenteric arteries. J. Pharmacol. Exp. Ther., 296, 322-328.
55. VARGA, K., LAKE, K.D., HUANGFU, D., GUYENET, P.G. & KUNOS, G. (1996). Mechanism of the hypotensive action of anandamide in anaesthetised rats. Hypertension, 28, 682-686.
56. VARGA, K., LAKE, K., MARTIN, B.R. & KUNOS, G. (1995). Novel antagonist implicates CB1 cannabinoid receptor in the hypotensive action of anandamide. Eur. J. Pharmacol., 278, 279-283.
57. VARGA, K., WAGNER, J.A., BRIDGEN, D.T. & KUNOS, G. (1998). Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension. FASEB J., 12, 1035-1044.
58. WAGNER, J.A., JÁRAI, Z., BATKAI, S. & KUNOS, G. (2001). Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors. Eur. J. Pharmacol., 423, 203-210.
59. 1 cannabinoid receptors in haemorrhagic shock. Nature, 390, 518-521.
60. WAGNER, J.A., VARGA, K., JÁRAI, Z & KUNOS, G. (1999). Mesenteric vasodilation mediated by endothelial anandamide receptors. Hypertension, 33, 429-434.
61. WHITE, R. & HILEY, C.R. (1997). A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery. Br. J. Pharmacol., 122, 1573-1584.
62. WHITE, R. & HILEY, C.R. (1998). The actions of some cannabinoid receptor ligands in the rat isolated mesenteric artery. Br. J. Pharmacol., 125, 533-541.
63. WHITE, R., HO, W.S., BOTTRILL, F.E., FORD, W.R. & HILEY, C.R. (2001). Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries. Br. J. Pharmacol., 134, 921-929.
64. 2 cannabinoid receptor-independent mechanism. J. Neurosci., 22, 4720.
65. ZYGMUNT, P.M., PETERSSON, J., ANDERSSON, D.A., CHUANG, H.H., SORGARD, M., DI MARZO, V., JULIUS, D. & HÖGESTATT, E.D. (1999). Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature, 400, 452-457.